FDA Orange Book · active-ingredient family
Protriptyline hydrochloride
Protriptyline hydrochloride is approved as 1 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:VIVACTIL · NDA 016012
1
Brand (NDA)
5
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| VIVACTIL×2 | TEVA WOMENS | NDA 016012 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (5)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PROTRIPTYLINE HYDROCHLORIDE×2 | EPIC PHARMA LLC | ANDA 202220 | AB | Nov 19, 2012 | |
| PROTRIPTYLINE HYDROCHLORIDE×2 | SIGMAPHARM LABS LLC | ANDA 090462 | AB | May 03, 2010 | |
| PROTRIPTYLINE HYDROCHLORIDE×2 | HIKMA | ANDA 078913 | — | Sep 16, 2008 | |
| VIVACTIL | CHARTWELL RX | ANDA 073644 | — | Aug 24, 1995 | |
| VIVACTIL | CHARTWELL RX | ANDA 073645 | — | Aug 24, 1995 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Protriptyline hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

